This is just the regular paid pump that precedes "newbie" news, a.k.a.: NDA submission. Roth Cap are paid shills. They run it up into news so they can dump their shares and buy again when it bottoms a few days/weeks later. Anyone who actually follows this stock knows it isn't worth $1.50 without a 2:1 RS and the bad news that follows it.
Nice strong personally insulting close there Jon Jon but it doesn't change either the FACTS, or the other,more pertinent fact.....that I am right...LOL ......and 'not for nothing' but most people find both accounting AND accountants pretty boring too......
They've got a lock on enough shareholder votes too....so they'll get what they want, regardless retail shareholder wishes.
You are correct. YOU ARE DUMB. What did you expect, to buy one day and profit the next? Hopefully you've learned from your loss but based solely on your grammar, I'm guessing your dumbness is permanent.
Approval or denial pending you mean. After all, the FDA denied it once before so that can certainly happen again. Everyone was certain it would be approved first round too. We even had a 10 to 2 panel vote for approval. Yet the FDA overruled. So, like many pricing this as a viable opportunity for ROI, I remain skeptical, albeit not cynical, about Probuphine's approval.
Yes it should have been in the .40s BECAUSE that's where the market priced it. Either you accept that the price is being manipulated or you don't....BUT you cannot have it both ways....LOL
You're calling me crazy JON?....and yet here you are too, six years or so later, posting as Paula2000, aka eastcoastjonny, aka Nowak/Novak the accountant extraordinaire/ aka resident stock know-it-all cum penny a page click financial investment journalist....LOL Some things are really hard to learn and even harder to unlearn Jon, so taking you to task for the above statement are at best, futile.....Meantime, you or all people should know that I couldn't care less about "rumors and 'little known' paths." As I'm certain I've stated DIRECTLY to you at least a hundred times right here on this board since 2009 Jon, I care about FACTS. An intelligent person sometimes quietly infers. I'd advise you might try it before posting here once in a while, as do I. It works wonders for the soul.
FYI: To any who don't already know...ID: eastcoastJONny is regular board poster Jon Novak, who also posts here as Nowak488 and Paula2000...Not casting aspersions, just informing the board....
After six years watching this stock's daily trading, I find it interesting how easily manipulated it is, always by small group traders (albeit with/without assistance from MMs.) Obviously this typical downward push, absent news, to our regular watchers means a growing desire by some for accumulation, since there is no selling without buyers is there? But I find this extensive price manipulation fascinating, since reason would indicate a supply and demand economy, even among near pinks like Titan. Watch and wonder, as do I, just how far they'll drop it this time. I think it's time to join in buying anywhere within this range where we're now trading, as the SP will definitely rise again to the high .90s, minimum, in my opinion. Thus, there's not much danger of losses....again, just my opinion. For whatever it's worth, if it hits the .40s again, I'm BUYING a butt load.
Given their history, I believe Titan will dilute LONG before any possibility of an approval. They're too smart not to take free money when it's available, especially given the uncertainty of an approval and the fact "creative financing scheming to dissolve shareholder equity" is all they've actually accomplished in their decades in business. Titan's a tremendous success at raising and then blowing, other people's money. If you go over their actual history, inception to date, that's the consistent pattern and no matter how you present this, it is irrefutable fact. Perpetuate the business regardless ROI, that's the mission. These reduced milestones, share swaps and other factors like the FDA relegating PB to a second-line, even IF approved, all spell around a .88 to .95 cent buyout offer to shareholders. My best guess is that will happen within 6 to 10 weeks from now. Even if they stayed the course and commercialized an approved Probuphine, with EXTRAORDINARY market success, it's doubtful today's shares would ever see $1.50 because they'll have drawn down any royalties and/or milestones while, accumulating disproportionate debt, issuing warrants and options left and right, all to finance another gravy train for insiders called ProNeura for Parkinson's, and a good bit before the company coffers see a dime in PB money. That little Park's gambit should play them well into 2025, as they screw over another generation of starry eyed believers.
You know jrfillion, both you and prospector2020 have a common valid point I hadn't considered: The "current" FDA. It's a distinct possibility that with new political leadership, all federal agencies could actually improve (and I'll resist the temptation to write something sarcastic that just naturally seems fitting after having written that statement....lol) But it's true. The FDA may actually come around on the idea of Pro Neura. Meantime it's also a fact that most government agencies, including FDA, cannot actually get much worse. And MOST DEFINITELY prospector2020,....Democrats had everything to do with it.
If you mean the guy who cried. Yeah, I remember him. I was sitting two chairs to his right for part of the panel and can tell you he was determined to make his point. Turns out his plea was pearls before swine, as those people, including Tit-Burn, all had their own agendas that day. I have no idea now why they even including that opportunity, since no one obviously either listened or cared a whit, at least where the FDA was concerned. Some of FDA's panel and its arbitrator, like Tit-Burn, were obviously sincere, others not so much. The FDA arbitrator was badly prepared and came off as a complete boob if you ask me. Everyone, as in the "friends of the panel," who spoke to the FDA was worth being heard and it's was more than a moving experience for me, to say the least. More than I can say for what the panelists brought. Even with a 10-2 vote, FDA balked? It was a fix.
Sounding my "broken record" speech as usual, FDA's delaying the approval of Probuphine, in addition to their "slapdown" relegating it to a second-line therapy, both smacks of either incompetence or internal corruption, perhaps both. It sure seemed to me both the Braeburn people and Titan's were sincere in their attempt to get the Adcomm to understand what they were presenting that day but frankly, after sitting through it I can tell you there were definitely a couple of VERY dull tools on that panel. For instance, does anyone else here recall the questions that were mostly commentary and which rambled on endlessly, only to arrive at a stupid answer printed on a page they'd not reviewed, although having been paid to do so? I thought the credentials of these panel people were supposed to relate to or be in support of the scientific discipline they were judging, but have since learned that five of them were qualified, the rest were partially or altogether NOT qualified to advise the FDA on the science and/or disease that Probuphine is designed to treat and in fact, in one "supposed" physician panelist's case, HE WASN'T EVEN LICENSED TO PRACTICE MEDICINE AT THE TIME OF THE ADCOMM. What a sham this whole thing has been, end to end. What's been hardest to figure out is just who is doing what to whom. The reason I remain affixed to the saga all these years. Frankly, it could go ANY way at this point, like one of those never ending soap operas, but in the final analysis, it's clear Titan's shareholders have been screwed.